Rethinking Dosage Optimization in Breast Oncology

At the 2024 San Antonio Breast Cancer Symposium®, a dynamic workshop on Dose Optimization in Breast Medical Oncology shed light on the shift away from how researchers have traditionally determined the dose for a new treatment by a model called maximum tolerated dose (MTD) and instead, use patient-centered approaches that balance effectiveness and quality of life. Moderated by Dr. Mirat […]